000538 雲南白藥
按盤價 
56.070 +0.070 (+0.125%)
56.070 +0.070 (+0.125%) | 2025/03 - 三個月 人民幣(K¥) | 與去年同期 比較 | 2024/12 人民幣(K¥) | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | ||
| 營業總收入 | 10,841,238 | 0.62% | 40,033,301 | 39,111,292 | 36,488,373 | 36,373,919 | |
| 減：營業總成本 | 8,751,172 | -2.60% | 35,206,797 | 35,082,750 | 32,087,168 | 31,739,818 | |
| 其中:營業成本 | 7,420,335 | -1.65% | 28,864,766 | 28,744,518 | 26,883,485 | 26,498,435 | |
| 財務費用 | (9,204) | -86.31% | (155,555) | (259,244) | (342,878) | (258,281) | |
| 資產減值損失 | (23,108) | -678.05% | (91,231) | (58,128) | (664,339) | (143,220) | |
| 公允價值變動收益 | 40,965 | -309.82% | 136,837 | 123,566 | (619,903) | (1,929,217) | |
| 投資收益 | 222,556 | -8.87% | 776,937 | 779,011 | 868,198 | 1,044,401 | |
| 其中：對聯營企業和合營企業的投資收益 | 233,248 | -12.43% | 774,280 | 628,532 | 732,233 | (21,100) | |
| 營業利潤 | 2,255,305 | 17.59% | 5,711,622 | 4,830,506 | 3,371,279 | 3,485,169 | |
| 利潤總額 | 2,255,981 | 17.52% | 5,684,720 | 4,818,012 | 3,377,002 | 3,481,646 | |
| 減：所得稅費用 | 328,470 | 48.87% | 917,647 | 695,451 | 536,593 | 683,986 | |
| 淨利潤 | 1,927,511 | 13.45% | 4,767,072 | 4,122,561 | 2,840,410 | 2,797,661 | |
| 減：非控股權益 | (7,128) | 147.08% | 17,657 | 28,779 | (160,716) | (7,256) | |
| 股東淨利潤 | 1,934,640 | 13.67% | 4,749,415 | 4,093,782 | 3,001,126 | 2,804,917 | |
市場價值指標 | |||||||
| 每股收益 (元) * | 1.080 | 13.68% | 2.660 | 2.290 | 1.900 | 2.210 | |
| 每股派息 (元) * | -- | -- | 2.398 | 2.077 | 1.520 | 1.600 | |
| 每股淨資產 (元) * | 22.849 | -1.26% | 21.764 | 22.194 | 21.428 | 29.800 | |
| 審計意見 # | -- | 标准的无保留意见 | 标准的无保留意见 | 标准的无保留意见 | 标准的无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 報價延遲最少15分鐘，資料更新時間為 11/07/2025 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
